Received Mar 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X017083 | — |
No adverse event; HCP called to report a child was administered an expired VAQTA vaccine. Lot/Expiration X017083 12/13/2024, administered 2/19/2025. Consent to contact is yes. No adverse side effects were reported. No additional information available at this time. N; This spontaneous report was received from a physician and refers to a 3-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 19-FEB-2025, the patient was vaccinated with an expired dose of with Hepatitis A Vaccine, Inactivated (VAQTA) (lot #X017083, who had been verified to be a valid lot number, expiration date reported and assessed as 13-DEC-2024) administered for prophylaxis (strength, exact dose, anatomical route of administration were not provided) (expired product administered). No adverse event.